
Read More
Pharmaceutical Company Gets USFDA Approval for Sodium Phosphates Injection...
The stock gave multibagger returns of 160 per cent in 3 years and a whopping 270 per cent in 5 years...

The stock gave multibagger returns of 160 per cent in 3 years and a whopping 270 per cent in 5 years...

This has been notified of a temporary suspension in the production of Lanreotide Injection....

This marks a historic milestone as the first and only treatment approved in the United States for Me...

The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-...

The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years...

The biosimilars division alongside niche product development represents Aurobindo Pharma's main focu...

The company's wholly-owned subsidiary, Nureca Technologies Pvt Ltd, specializes in manufacturing med...

The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-...

The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site op...

With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product port...